IN8BIO, INC. — Director's Dealing 2023

Dec 15, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IN8BIO, INC. (INAB)
CIK: 0001740279
Period of Report: 2023-12-13

Reporting Person: Ho William Tai-Wei (Director, President and CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-12-13	Common Stock	A	81967	—	Acquired	2421512	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-12-13	Series A Warrants (right to buy)	$1.25	A	81967	Acquired	2025-06-13	Common Stock (81967)	Direct
2023-12-13	Series B Warrants (right to buy)	$1.50	A	81967	Acquired	2028-12-13	Common Stock (81967)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	72999	Indirect
Common Stock	73000	Indirect
Common Stock	36500	Indirect
Common Stock	36500	Indirect
Common Stock	36500	Indirect

Footnotes

F1: The reported securities are included within 81,967 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 81,967 shares of common stock.

F2: The shares are held by a relative of the Reporting Person. The Reporting Person has voting power pursuant to a voting proxy.

F3: Fully vested and exercisable.